Najla Altwaijry
Affiliations: | 2018 | University of Strathclyde, Glasgow, Scotland, United Kingdom |
Google:
"Najla Altwaijry"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Thapa R, Gupta G, Bhat AA, et al. (2023) A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies. International Journal of Biological Macromolecules. 253: 127375 |
Alsfouk AA, Alshibl HM, Altwaijry NA, et al. (2021) Synthesis and biological evaluation of seliciclib derivatives as potent and selective CDK9 inhibitors for prostate cancer therapy Monatshefte FüR Chemie - Chemical Monthly. 152: 109-120 |
Sabour R, Harras MF, Mohamed Al Kamaly O, et al. (2020) Discovery of Novel 3-Cyanopyridines as Survivin Modulators and Apoptosis Inducers. Molecules (Basel, Switzerland). 25 |
Laskar P, Somani S, Altwaijry N, et al. (2018) Redox-sensitive, cholesterol-bearing PEGylated poly(propylene imine)-based dendrimersomes for drug and gene delivery to cancer cells. Nanoscale |
Altwaijry N, Somani S, Dufès C. (2018) Targeted nonviral gene therapy in prostate cancer. International Journal of Nanomedicine. 13: 5753-5767 |
Somani S, Laskar P, Altwaijry N, et al. (2018) PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells. Scientific Reports. 8: 9410 |
Altwaijry N, Somani S, Parkinson JA, et al. (2018) Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12. Drug Delivery. 25: 679-689 |